Trial of Family Focused Grief Therapy in Palliative Care and Bereavement
Randomized Controlled Trial of Family Focused Grief Therapy in Palliative Care and Bereavement
2 other identifiers
interventional
700
1 country
3
Brief Summary
The purpose of this study is to learn how well family therapy works if given while a family member is being treated for a serious illness and whether it helps their family to continue meeting for a time after their death. The therapy aims to assist the family communication and support during both palliative care and bereavement. The investigators also want to learn how many family therapy sessions spread out over time are best for helping patients and their families. Patients are randomly assigned to one of three groups: patients who receive standard palliative care, patients and their families who take part in 6 sessions, and patients and their families who take part in 10 sessions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable cancer
Started Nov 2005
Longer than P75 for not_applicable cancer
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 8, 2005
CompletedFirst Submitted
Initial submission to the registry
December 20, 2007
CompletedFirst Posted
Study publicly available on registry
December 24, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 11, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 11, 2026
CompletedMarch 13, 2026
March 1, 2026
20.4 years
December 20, 2007
March 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluate the efficacy and dose responsiveness of family intervention in preventing bereavement and depression compared with standard palliative care among family members and to examine whether distress moderates impact of FFGT
5 years
Secondary Outcomes (1)
Evaluate whether family coping and communication mediate the impact of FFGT and examine costs of FFGT and standard palliative care, and whether the additional costs are offset by reductions in community health utilization
5 years
Study Arms (3)
1
EXPERIMENTAL6 sessions of Family Focused Group Therapy
2
EXPERIMENTAL10 Sessions of Family Focused Group Therapy
3
ACTIVE COMPARATORStandard Care- Social work consultations are routinely provided to the cancer patients, but relatives are only seen during admissions or upon request
Interventions
Standard of Care Families assigned to the Usual Care Condition will receive standard psychosocial care which is based on the following patterns: Social work consultations are routinely provided to the cancer patients, but relatives are only seen during admissions or upon request.
6 Sessions of Family Focused Group Therapy (FFGT). The FFGT intervention will have assessment, focused therapy, consolidation, and termination phases. The first two sessions are assessment sessions and occur one week apart. There will be two or six focused intervention sessions depending on the predetermined length of therapy. The first focused intervention session is approximately two weeks after the last assessment session. Subsequent focused intervention sessions are expected to follow once every month. Finally, there will be two consolidation/termination sessions, which will occur one time each, approximately two months apart. The six session program is expected to extend over a period of 6 months and the 10 session program over 10 months.
Eligibility Criteria
You may qualify if:
- Individuals with advanced disease/Stage 4-IV cancer who may be involved in palliative care treatment program.
- Per investigator's judgment participants must have satisfactory cognitive functioning to provide valid informed consent and participate in family therapy.
- In the event that the index family member is declining or too frail to take part in family meetings, the family is able to participate without the index patient being involved in the study.
- For every enrolled family there must be at least 2 family members willing/able to take part at the time of recruitment.
- The presence of FRI screening scores of ≤ 9 or cohesiveness subscale score \< 4 based on the perception of any single family member, including the patient.
You may not qualify if:
- Inability through language to complete the study questionnaires - inability to speak English with an English-speaking therapist.
- Age less than 12 years old for a child.
- Patient and family member determined geographical inaccessibility to attend family sessions.
- Significant psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in a psychotherapeutic intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Memorial Sloan Kettering Cancer Centerlead
- National Cancer Institute (NCI)collaborator
- Beth Israel Medical Centercollaborator
- Calvary Hospital, Bronx, NYcollaborator
- Monash Universitycollaborator
Study Sites (3)
Beth Israel Hospice Program
New York, New York, 10003, United States
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065, United States
Calvary Hospital
The Bronx, New York, 10461, United States
Related Links
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Talia Zaider, PhD
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 20, 2007
First Posted
December 24, 2007
Study Start
November 8, 2005
Primary Completion
March 11, 2026
Study Completion
March 11, 2026
Last Updated
March 13, 2026
Record last verified: 2026-03